People: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

3.27USD
5 May 2015
Change (% chg)

$-0.06 (-1.80%)
Prev Close
$3.33
Open
$3.29
Day's High
$3.33
Day's Low
$3.15
Volume
644,325
Avg. Vol
956,415
52-wk High
$5.10
52-wk Low
$1.70

Search Stocks

McEnany, Patrick 

Mr. Patrick J. McEnany is the Chairman of the Board, President, Chief Executive Officer of Catalyst Pharmaceutical Partners, Inc. Mr. McEnany has been CEO and a director since formation in January 2002. He became Chairman and President in March 2006. From 1999 to 2002, Mr. McEnany was a consultant to the pharmaceutical industry. From 1991 to 1997, Mr. McEnany was Chairman and CEO of Royce Laboratories, Inc., a generic pharmaceutical manufacturer. From 1997 to 1998, after the merger of Royce into Watson Pharmaceuticals, Inc., Mr. McEnany served as president of the wholly-owned Royce Laboratories subsidiary and vice president of corporate development for Watson Pharmaceuticals, Inc. From 1993 to 1997, he also served as vice chairman and a director of the National Association of Pharmaceutical Manufacturers. He currently serves on the board of directors of CESCA Therapeutics Inc. (f/k/a ThermoGenesis Corp.) and the Jackson Memorial Hospital Foundation, and over the last 30 years has served as a director for numerous other public companies. The Board of Directors believes the characteristics that qualify Mr. McEnany for election to the Board include his long-term experience in the pharmaceutical industry and his business leadership experience.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
510,000 -- 734,487 1,470,890

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

1,470,890

Alicia Grande

714,113

Steven Miller

863,334

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of  30 Dec 2014
Search Stocks